These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 22867776)
1. Validation of the UFS-QOL-hysterectomy questionnaire: modifying an existing measure for comparative effectiveness research. Coyne KS; Margolis MK; Murphy J; Spies J Value Health; 2012; 15(5):674-9. PubMed ID: 22867776 [TBL] [Abstract][Full Text] [Related]
2. Further validation of the uterine fibroid symptom and quality-of-life questionnaire. Coyne KS; Margolis MK; Bradley LD; Guido R; Maxwell GL; Spies JB Value Health; 2012 Jan; 15(1):135-42. PubMed ID: 22264981 [TBL] [Abstract][Full Text] [Related]
3. Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire. Coyne KS; Soliman AM; Margolis MK; Thompson CL; Chwalisz K Curr Med Res Opin; 2017 Feb; 33(2):193-200. PubMed ID: 27733082 [TBL] [Abstract][Full Text] [Related]
4. The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). Harding G; Coyne KS; Thompson CL; Spies JB Health Qual Life Outcomes; 2008 Nov; 6():99. PubMed ID: 19014505 [TBL] [Abstract][Full Text] [Related]
5. Initial experience of uterine fibroid embolization using porous gelatin sponge particles. Katsumori T; Kasahara T; Oda M; Kotani T Cardiovasc Intervent Radiol; 2011 Jun; 34(3):513-21. PubMed ID: 20574795 [TBL] [Abstract][Full Text] [Related]
6. [Change in health-related quality of life and change in clinical symptoms after uterine artery embolization in patients with symptomatic adenomyosis uteri - evaluation using a standardized questionnaire]. Froeling V; Scheurig-Muenkler C; Steffen IG; Schreiter NF; Kröncke TJ Rofo; 2012 Jan; 184(1):48-52. PubMed ID: 22161234 [TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids. Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594 [TBL] [Abstract][Full Text] [Related]
8. Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL NL) in the Dutch population: a validation study. Keizer AL; van Kesteren PJM; Terwee C; de Lange ME; Hehenkamp WJK; Kok HS BMJ Open; 2021 Nov; 11(11):e052664. PubMed ID: 34815284 [TBL] [Abstract][Full Text] [Related]
9. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids. Anchan RM; Spies JB; Zhang S; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL Am J Obstet Gynecol; 2023 Sep; 229(3):275.e1-275.e17. PubMed ID: 37244458 [TBL] [Abstract][Full Text] [Related]
10. Uterine artery embolization for symptomatic fibroids: long-term changes in disease-specific symptoms and quality of life. Scheurig-Muenkler C; Lembcke A; Froeling V; Maurer M; Hamm B; Kroencke TJ Hum Reprod; 2011 Aug; 26(8):2036-42. PubMed ID: 21642637 [TBL] [Abstract][Full Text] [Related]
11. Laparoscopically assisted uterine fibroid cryoablation. Pansky M; Cowan BD; Frank M; Hampton HL; Zimberg S Am J Obstet Gynecol; 2009 Dec; 201(6):571.e1-7. PubMed ID: 19716538 [TBL] [Abstract][Full Text] [Related]
12. MRI assessment of uterine artery patency and fibroid infarction rates 6 months after uterine artery embolization with nonspherical polyvinyl alcohol. Das R; Gonsalves M; Vlahos I; Manyonda I; Belli AM Cardiovasc Intervent Radiol; 2013 Oct; 36(5):1280-7. PubMed ID: 23385663 [TBL] [Abstract][Full Text] [Related]
13. Uterine artery embolization for symptomatic fibroids: short-term versus mid-term changes in disease-specific symptoms, quality of life and magnetic resonance imaging results. Scheurig C; Gauruder-Burmester A; Kluner C; Kurzeja R; Lembcke A; Zimmermann E; Hamm B; Kroencke T Hum Reprod; 2006 Dec; 21(12):3270-7. PubMed ID: 16877371 [TBL] [Abstract][Full Text] [Related]
14. The FIBROID Registry: symptom and quality-of-life status 1 year after therapy. Spies JB; Myers ER; Worthington-Kirsch R; Mulgund J; Goodwin S; Mauro M; Obstet Gynecol; 2005 Dec; 106(6):1309-18. PubMed ID: 16319257 [TBL] [Abstract][Full Text] [Related]
16. Uterine Fibroid Symptom and Health-related Quality of Life Questionnaire: a Chinese translation and validation study. Yeung SY; Kwok JWK; Law SM; Chung JPW; Chan SSC Hong Kong Med J; 2019 Dec; 25(6):453-459. PubMed ID: 31796639 [TBL] [Abstract][Full Text] [Related]
17. [Clinical outcome of magnetic-resonance-guided focused ultrasound surgery (MRgFUS) in the treatment of symptomatic uterine fibroids]. Kamp JE; David M; Scheurig-Muenkler C; Hengst S; Beck A Rofo; 2013 Feb; 185(2):136-43. PubMed ID: 23196835 [TBL] [Abstract][Full Text] [Related]
18. Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization. Goldberg J; Bussard A; McNeil J; Diamond J Cardiovasc Intervent Radiol; 2007; 30(1):54-8. PubMed ID: 17031734 [TBL] [Abstract][Full Text] [Related]
19. Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry. Goodwin SC; Spies JB; Worthington-Kirsch R; Peterson E; Pron G; Li S; Myers ER; Obstet Gynecol; 2008 Jan; 111(1):22-33. PubMed ID: 18165389 [TBL] [Abstract][Full Text] [Related]